GA-BIOLOG-ID
9.6.2020 14:02:07 CEST | Business Wire | Press release
Biolog-id, LLC, a world leader in connected solutions for blood and other high value health products, announced today that LifeShare Blood Center, a leading provider of blood products in the South Central United States, implemented Biolog-id’s RFID-enabled, data analytics solution in its blood supply chain. The deployed solution provides real-time visibility to convalescent plasma from collection to distribution, streamlining inventory, improving efficiency, and ultimately maximizing Return on Donation. Better visibility to the inventory facilitates efficient management of convalescent plasma, and so increases the availability of these scarce and valuable antibodies to the COVID-19 patients who need them.
“Biolog-id LLC has been a strategic partner to our industry, filling a gap in the timely delivery of convalescent plasma,” said Monica Kalvelage, Chief Operations Officer, of LifeShare Blood Center. “Their innovative technology automates a crucial process, enabling a more efficient inventory management and delivery of critical convalescent plasma to COVID-19 patients.”
“The ability to quickly respond to changes in market needs is key to Biolog-id,” said Amit Mayer, VP Innovation & Analytics at Biolog-id LLC. “As a team we were able to move from defining the Covid-19 convalescent plasma solution to implementing it within weeks, all in close cooperation with LifeShare.”
“Convalescent plasma presents LifeShare Blood Center with an incredible opportunity to positively impact the population they serve. Facilitating their move to a digital future on our platform has been a pleasure,” said Troy L. Hilsenroth, CEO Biolog-id LLC. “We are at an exciting time in Biolog-id's evolution as organizations continue to adopt our solutions to unlock desired operational, clinical, and financial value.
Enabling a new standard of care of how high-value products in healthcare are distributed, stored, utilized, and tracked are central to Biolog-id LLC’s vision.
About Biolog-id
Biolog-id has developed a patented smart solution for the management and traceability of sensitive, high-value health products throughout the hospital supply chain to ensure safe delivery from donor to patient. Biolog-id operates in North America, Europe, Middle East, India and Asia Pacific region and has 100 employees worldwide. Biolog-id is owned by its founder, managers, and the Xerys Funds.
Company URL : www.biolog-id.com
About LifeShare Blood Center
In 1942 civic-minded residents who realized a blood bank was needed for emergencies created by WWII, founded the Shreveport Memorial Blood Bank. Operating as a nonprofit organization, during its 70 years the blood bank has had different names to reflect its growth. It is now LifeShare Blood Center, operating throughout much of Louisiana, plus east Texas and southern Arkansas.
Company URL: www.lifeshare.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20200609005036/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gaétane Baudry Appointed Senior Vice President/Global General Manager, Bobbi Brown8.10.2026 14:00:00 CEST | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Gaétane Baudry as Senior Vice President/Global General Manager, Bobbi Brown, effective October 8, 2026. Based in New York, she will report to Lisa Sequino, Global President, Makeup Brands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261008525584/en/ Gaétane Baudry In this role, Gaétane will lead Bobbi Brown’s global strategy and continued evolution, strengthening the brand’s distinctive equity, advancing innovation and creativity, and deepening consumer engagement around the world. “Gaétane is an inspiring and highly collaborative leader who brings experience, energy and a strong focus on execution,” said Lisa Sequino, Global President, Makeup Brands. “Her global brand-building record, strong commercial leadership and passion for creating meaningful consumer experiences will be invaluable as Bobbi Brown builds on its unique brand equity focused
Adtran launches Mosaic One Agents to help teams easily scale operations8.10.2026 14:00:00 CEST | Press release
News summary: Rapidly growing networks, operations and customer demands call for new ways to scale expertise Mosaic One Agents provides role-specific AI agent teams for network management, customer care and business operations Agent teams use data from Adtran and third-party hardware to investigate problems in parallel while organizations retain control Adtran today launched Mosaic One Agents, a suite of AI agents designed to help organizations scale expertise across network management, customer care and business operations. Built on Mosaic One Fabric, it gives role-based agent teams access to data from Adtran and third-party networks, enabling them to investigate issues, coordinate work across teams and drive issues through to resolution. By handling time-consuming investigation, coordination and process tasks, Mosaic One Agents helps people resolve issues faster, extend their expertise across more workflows and retain control of critical network and business actions. “When something
The LYCRA Company to Spotlight Renewable LYCRA® Fiber and Textile-to-Textile Circularity at Textile Exchange Conference 20268.10.2026 14:00:00 CEST | Press release
The LYCRA Company, a global leader in fiber and technology solutions for the apparel and personal care industries, will showcase Renewable LYCRA® fiber and its work to advance textile-to-textile recycling at Textile Exchange Conference 2026. The conference takes place October 12–16, at the Vancouver Convention Centre in Vancouver, Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261008178765/en/ At the Textile Exchange Conference 2026, The LYCRA Company will showcase Renewable LYCRA® fiber and its progress in advancing textile-to-textile recycling. This year's theme, "The Implementation Era," focuses on scaling what works across businesses, supply systems, and landscapes. At the conference, The LYCRA Company will highlight its work with partners across the value chain, helping to shape the future for textiles through renewable fiber solutions, circular innovation, and strategic industry partnerships. “Bringing more rec
ARIS Strengthens Global Leadership Team with Three Senior Appointments to Accelerate 2027 Growth8.10.2026 14:00:00 CEST | Press release
Process Context Platform for Enterprise AI adds new Chief Product Officer, Global Head of Strategy & Transformation and Americas sales lead to help capitalize on growing enterprise demand for trusted, scalable AI ARIS, the global leader in Process Context for Enterprise AI, today announced three new senior appointments as it builds momentum toward 2027 and accelerates its strategy to help organizations put AI to work at scale. Maxime Hambersin joins as Chief Product Officer, Dr. Benjamin Krusche as Global Head of Strategy & Transformation, and Mark Jacobs as President and Go-to-Market Lead, Americas. The appointments further strengthen the leadership team built around CEO Guillaume Bacuvier and support the company's next phase of global growth. They come as ARIS advances its positioning around Process Context – giving AI agents the business understanding they need to operate effectively – while accelerating a product roadmap designed to help enterprises identify, deploy and scale AI ag
Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer8.10.2026 13:30:00 CEST | Press release
Botvymo® (botensilimab) and Evamplix® (balstilimab) receive separate approvals for use in combinationArmenia is the first country to approve marketing authorization of BOT+BAL, following a rigorous review of quality, nonclinical, clinical and pharmacovigilance dataApprovals supported by clinical evidence published in peer-reviewed journals and presented at major oncology congresses, including two-year Phase 1b survival findings and randomized Phase 2 data in MSS metastatic colorectal cancer without active liver metastasesAgenus will evaluate the potential for approvals in other Eurasian Economic Union countries that support this regulatory path Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Ministry of Health of the Republic of Armenia has granted marketing authorizations for Botvymo® (botensilimab, BOT) and Evamplix® (balstilimab, BAL), each approved for use in combination with the other for the treatment of adult patients with microsatell
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom